2026 ICD-10-CM Diagnosis Code Q77.1Thanatophoric short stature
ICD-10-CM Codes›Q00-Q99›Q65-Q79›Q77
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q77.1 is a billable ICD-10-CM diagnosis code for thanatophoric short stature. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 564 through 566. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Musculoskeletal congenital conditions.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q77.1 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Defects of the tubular bones and/or axial skeleton
- Disproportionate short stature
- Lethal congenital disproportionate short limbed short stature
- Thanatophoric dysplasia
- Thanatophoric dysplasia, type 1
- Thanatophoric dysplasia, type 2
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Dwarfism - See Also: Short, stature; - E34.328
- thanatophoric - Q77.1
- Thanatophoric dwarfism or short stature - Q77.1
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Dwarfism
- thanatophoric
- Thanatophoric dwarfism or short stature
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Thanatophoric Dysplasia
a severe form of neonatal dwarfism with very short limbs. all cases have died at birth or later in the neonatal period.Thanatophoric Dysplasia
a severe autosomal dominant inherited disorder caused by mutations in the fgfr3 gene. it is characterized by multiple skeletal abnormalities, including extremely short limbs. it results in the death of the neonate.Type 1 Thanatophoric Dysplasia|Thanatophoric Dysplasia, Type 1
thanatophoric dysplasia characterized by a normally shaped skull and curved femurs. it is the most common type of thanatophoric dysplasia.Type 2 Thanatophoric Dysplasia|Thanatophoric Dysplasia, Type 2
thanatophoric dysplasia characterized by a cloverleaf-like skull and straight femurs.
Patient EducationClinical
Birth Defects
A birth defect is a problem that happens while a baby is developing in the mother's body. Most birth defects happen during the first 3 months of pregnancy. One out of every 33 babies in the United States is born with a birth defect.
The full article covers:
- What are birth defects?
- What causes birth defects?
- Who is at risk of having a baby with birth defects?
- How are birth defects diagnosed?
- What are the treatments for birth defects?
- Can birth defects be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Q77.1 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Q77.1Overview
Is Q77.1 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report thanatophoric short stature on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does Q77.1 group to?
When thanatophoric short stature is the principal diagnosis on an inpatient stay, it groups to MS-DRG 564, 565, 566, with relative weights from 0.7493 to 1.5436 depending on complications. Higher weights mean higher Medicare reimbursement.
Is Q77.1 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for thanatophoric short stature on inpatient claims.
What is the ICD-9 equivalent of Q77.1?
Under the General Equivalence Mappings, thanatophoric short stature converts to ICD-9-CM 756.4 (chondrodystrophy). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
